Activity Goals. Case 1: MDS. Evaluation for Transplant. CCI Impacts Survival. Patient Characteristics -- MDS. HSCT for AML and MDS By Age: TRM and Relapse. Overall Survival: HSCT for MDS By Age. Conditioning Regimens. Pharmacokinetics: Goal of Therapy. - PowerPoint PPT Presentation
Transcript of Activity Goals
Activity Goals
Case 1: MDS
Evaluation for Transplant
CCI Impacts Survival
Patient Characteristics -- MDS
HSCT for AML and MDS By Age: TRM and Relapse
Overall Survival: HSCT for MDS By Age
Conditioning Regimens
Pharmacokinetics: Goal of Therapy
Implications of Altered Drug Distribution of Bu
Improving Outcomes
Response to Azacitidine: IWG Criteria ITT Cohort (n = 282)
New Cytogenetic Scoring System in MDS
Survival by 5-group Cytogenetic Classification
Azacitidine After Allo-SCT
3-Year OS Based On Pretransplantation Treatment
Case 2: Myeloma Transformed into AML
Life Expectancy at Age 65 Years and 85 Years by Gender